Saudi Arabia’s Health Ministry has announced strict new penalties targeting health practitioners and facilities that prescribe or dispense weight-loss injections without medical supervision, citing serious risks to public health.
The ministry said offenders could face fines of up to 100,000 riyals, revocation of their licenses, and up to six months in prison.
The crackdown, part of a wider inspection campaign, also prohibits marketing weight-loss drugs without a valid prescription.
Health officials warned that unsupervised use of such medications can cause dangerous side effects, including rapid heart rate, low blood sugar, and pancreatitis.
Long-term or unmonitored use could lead to chronic conditions such as digestive disorders and higher risk of weight regain once treatment stops.
The announcement comes as obesity rates rise in the kingdom. According to the Saudi General Authority for Statistics, 23.1 percent of residents aged 15 and older are obese, while 45.1 percent are overweight.
Many patients are increasingly turning to unprescribed weight-loss drugs, heightening fears among health experts about long-term safety.
The ministry urged the public to seek medical advice before using such treatments and called on pharmacies and practitioners to strictly follow regulations on dispensing.
It pledged to continue inspection campaigns and to take action against violators, including imposing financial penalties and withdrawing licenses. Citizens were encouraged to report violations to ensure public safety and protect patients from harm.
